Rare diseases
Investigational molecules
Locations
200 Smith Street, 02451-0099, United States
Deciphera Pharmaceuticals Inc. focuses on advanced gastrointestinal stromal tumor (GIST), including patients with prior imatinib treatment, and related malignant solid tumors. Its clinical research also extends to metastatic solid tumor settings and broader advanced tumor populations.
The sponsor’s portfolio includes studies in KIT-mutant disease and other solid tumor contexts where targeted treatment options remain limited.
Deciphera Pharmaceuticals Inc. runs clinical trials in conditions such as Gastrointestinal stromal tumour, Polycythaemia vera, Central nervous system lymphoma, Neoplasm, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaAustria
Denmark
FranceFranceFranceFranceFranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
